S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
Log in

Nymox Pharmaceutical Earnings Date, Estimates & History (NASDAQ:NYMX)

$3.22
+0.09 (+2.88 %)
(As of 02/20/2020 04:00 PM ET)
Today's Range
$3.01
Now: $3.22
$3.33
50-Day Range
$2.20
MA: $3.12
$3.88
52-Week Range
$1.32
Now: $3.22
$4.09
Volume401,757 shs
Average Volume283,555 shs
Market Capitalization$225.30 million
P/E RatioN/A
Dividend YieldN/A
Beta1.81

Earnings

Nymox Pharmaceutical (NASDAQ:NYMX) Earnings Information

Nymox Pharmaceutical last released its earnings data on November 13th, 2019. The biopharmaceutical company reported ($0.04) EPS for the quarter. The firm had revenue of $0.04 million for the quarter. Nymox Pharmaceutical has generated $0.00 earnings per share over the last year. Nymox Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 3rd, 2020 based off prior year's report dates.

Nymox Pharmaceutical Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Nymox Pharmaceutical (NASDAQ NYMX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
4/3/2020
(Estimated)
       
11/13/2019Q3 2019($0.04)($0.04)$0.04 millionN/A
8/14/2019Q2 2019($0.08)($0.08)$0.02 millionN/A
5/15/2019Q1 2019($0.04)($0.04)$0.03 millionN/A
3/29/2019Q4 2018($0.05)($0.05)$0.02 millionN/A
11/13/2018Q3 2018($0.05)($0.05)$0.04 millionN/A
8/13/2018Q2 2018($0.04)($0.04)$0.09 millionN/A
5/15/2018Q1 2018($0.05)($0.05)$0.15 millionN/A
3/30/2018Q4 2017($0.06)($0.06)$0.11 millionN/A
11/6/2017Q3 2017($0.09)($0.09)$0.03 millionN/A
8/7/2017Q2 2017($0.05)($0.05)$0.01 millionN/A
5/15/2017Q1 2017($0.06)($0.06)$0.08 millionN/A
3/31/2017Q4 2016($0.06)($0.06)$0.04 millionN/A
11/15/2016Q3 2016($0.07)($0.07)$0.05 millionN/A
8/22/2016Q2 2016($0.08)($0.08)$0.15 millionN/A
5/16/2016Q1 2016($0.07)($0.07)$0.04 millionN/A
3/30/2016Q4 2015($0.10)($0.10)$0.08 millionN/A
12/31/2015Q3 2015($0.26)($0.26)$0.05 millionN/A
8/24/2015Q2 2015($0.63)($0.63)$0.06 millionN/A
5/15/2015Q1 2015$0.04$0.04$0.08 millionN/A
3/31/2015Q4 2014($0.01)($0.01)$0.08 millionN/A
11/14/2014Q314($0.02)($0.02)$0.08 millionListen
8/11/2014Q2 2014($0.02)($0.02)$0.10 millionN/A
5/15/2014Q1 2014($0.07)($0.07)$0.08 millionN/A
3/14/2014Q4 2013($0.03)($0.03)$0.94 millionN/A
11/14/2013Q3 2013($0.03)($0.03)$0.74 millionN/A
8/14/2013Q2 2013($0.04)($0.04)$0.19 millionN/A
5/15/2013Q1 2013($0.03)($0.03)$0.78 million$0.18 millionListen
3/15/2013Q4 2012($0.05)($0.08)($0.08)N/A
11/14/2012Q312($0.06)($0.04)N/A
8/14/2012Q2 2012($0.06)($0.05)($0.05)N/A
5/15/2012Q1 2012($0.06)($0.06)($0.06)N/A
3/15/2012Q4 2011($0.06)($0.06)($0.06)N/A
11/14/2011Q3 2011($0.05)($0.05)($0.05)N/A
8/12/2011Q2 2011($0.04)($0.06)($0.06)N/A
5/13/2011Q1 2011($0.05)($0.14)($0.14)N/A
3/15/2011Q4 2010($0.05)($0.07)($0.07)N/A
11/12/2010Q3 2010($0.05)($0.05)N/A
8/13/2010Q2 2010($0.05)($0.05)N/A
5/14/2010Q1 2010($0.04)($0.04)N/A
3/11/2010Q4 2009($0.05)($0.05)N/A
11/13/2009Q3 2009($0.04)($0.04)N/A
8/14/2009Q2 2009($0.04)($0.04)N/A
5/15/2009Q1 2009($0.03)($0.03)N/A
11/14/2008Q3 2008($0.05)($0.05)N/A
8/13/2008Q2 2008($0.04)($0.04)N/A
5/14/2008Q1 2008($0.04)($0.04)N/A
3/14/2008Q4 2007($0.04)($0.04)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Featured Article: Roth IRA

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel